SynthesisFrontiers in endocrinology2021

Patients With Type 2 Diabetes Mellitus and Heart Failure Benefit More From Sodium-Glucose Cotransporter 2 Inhibitor: A Systematic Review and Meta-Analysis.

Chengcong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.